首页> 外文期刊>The Journal of Veterinary Medical Science >Immunohistochemical Analysis of Molecular Events in Tubulo-Interstitial Fibrosis in a Mouse Model of Diffuse Mesangial Sclerosis (ICGN Strain)
【24h】

Immunohistochemical Analysis of Molecular Events in Tubulo-Interstitial Fibrosis in a Mouse Model of Diffuse Mesangial Sclerosis (ICGN Strain)

机译:弥漫性肾小球硬化(ICGN株)小鼠模型中肾小管间质纤维化分子事件的免疫组织化学分析。

获取原文
           

摘要

References(45) Cited-By(3) Diffuse mesangial sclerosis (DMS) is one of the hereditary glomerular diseases and histologically characterized by severe glomerulosclerosis and subsequent tubulo-interstitial fibrosis (TIF). In DMS patients, renal dysfunction correlates well with TIF, rather than with glomerular lesions. Thus, molecular mechanisms whereby TIF in DMS progresses should be addressed. Previously, we found that nephrotic ICGN mice manifest DMS-like lesions and develop renal dysfunction in accordance with onset of TIF. In the present study, we investigated fibrogenic events involved in the progression of TIF after DMS manifestation, using the DMS mouse model. Immunohistochemistry revealed that expression of transforming growth factor-beta (TGF-β) was rare in the interstitial cells of the nephrotic mice at the early-stage of DMS, while the TGF-β expression became evident in the late-stage DMS mice. Platelet-derived growth factor (PDGF) was mildly expressed in the distal tubules of the early-stage DMS mice, whereas the PDGF expression markedly increased at the late-stage of DMS. As a result, α-actin-positive myofibroblastic cells were found dominant in the interstitial spaces of the late-stage DMS mice. Finally, TIF became severe in accordance with the overexpressions of these molecules. Our results suggest that in our murine model: 1) persistent proteinuria leads to over-expression of TGF-β and PDGF in non-glomerular areas; 2) these cytokines provoke interstitial myofibroblast accumulation; and 3) the myofibroblasts produce fibrotic matrix proteins in the interstitial spaces. This process may possibly contribute to the development of TIF in DMS patients.
机译:参考文献(45)被引用(3)弥漫性肾小球膜硬化症(DMS)是遗传性肾小球疾病之一,其组织学特征是严重的肾小球硬化症和随后的肾小管间质纤维化(TIF)。在DMS患者中,肾功能不全与TIF相关,而不与肾小球病变相关。因此,应解决DMS中TIF进展的分子机制。以前,我们发现肾病性ICGN小鼠表现出DMS样病变并根据TIF发作发展为肾功能不全。在本研究中,我们使用DMS小鼠模型调查了DMS表现后TIF进程中涉及的纤维化事件。免疫组织化学显示,在DMS早期,肾病小鼠的间质细胞中很少有转化生长因子-β(TGF-β)的表达,而在DMS后期,TGF-β的表达变得明显。血小板衍生的生长因子(PDGF)在早期DMS小鼠的远端小管中轻度表达,而PDGF的表达在DMS晚期显着增加。结果,发现α-肌动蛋白阳性的肌成纤维细胞在晚期DMS小鼠的间隙中占优势。最后,根据这些分子的过表达,TIF变得严重。我们的结果表明,在我们的鼠模型中:1)持续性蛋白尿导致非肾小球区域TGF-β和PDGF的过度表达; 2)这些细胞因子引起间质性成纤维细胞的积累; 3)成肌纤维细胞在间隙中产生纤维化基质蛋白。此过程可能有助于DMS患者中TIF的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号